Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease (COPD)
MedTech
Galvanize nets $100M, and a new CEO, to bring PFA to lung cancer
The company has named its chairman, Doug Godshall, as CEO amid a $100 million series C venture capital fundraising.
Conor Hale
Sep 4, 2025 1:00pm
Expedition inks $645M Fosun deal to bring China asset to US
Aug 11, 2025 11:06am
Apreo Health nets $130M to develop lung scaffold for emphysema
Aug 8, 2025 11:30am
GSK strengthens COPD offering via $12B biobucks Hengrui deal
Jul 28, 2025 4:36am
Roche's COPD drug flunks ph. 3, denting hopes of 2025 approval
Jul 21, 2025 4:38am
Sanofi's IL-33 drug fails COPD study
May 30, 2025 5:30am
